MODEL 2004FAA MODEL 3-EEMK MODEL 3-EEMK-1 MODEL AA-8565 MODEL AA-8565-LATAM MODEL AWFAREMK MODEL CHAUTAUQUAEMK MODEL EMK1000-10 MODEL FAREMK MODEL PMONTFAREMK MODEL SWEEMK MODEL SWEEMK-1 MODEL QXEMK MODEL G4FAREMK MODEL AA-8565 (EXCLUDING MIAMI AIR)
emergency response safety kit kit |
Product Information |
Product Type | MEDICAL DEVICE | Item Code (Source) | NHRIC:27860-001 |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NHRIC:27860-001-13 | 1 in 1 PACKAGE; Type 1: Convenience Kit of Co-Package | | |
|
Quantity of Parts |
Part # | Package Quantity | Total Product Quantity |
Part 1 | | 1 |
Part 2 | | 1 |
Part 3 | | 1 |
Part 4 | | 1 |
Part 5 | | 1 |
Part 6 | | 1 |
Part 7 | | 1 |
Part 8 | | 1 |
Part 9 | | 1 |
Part 10 | | 1 |
Part 11 | | 1 |
Part 12 | | 1 |
Part 13 | | 1 |
Part 14 | | 1 |
Part 15 | | 1 |
Part 16 | | 1 |
Part 17 | | 1 |
Part 18 | | 1 |
Part 19 | | 1 |
Part 20 | | 1 |
Part 21 | | 1 |
Part 22 | | 1 |
Part 23 | | 1 |
Part 24 | | 1 |
Part 25 | | 1 |
Part 26 | | 1 |
Part 27 | | 1 |
|
Part 1 of 27 |
SODIUM CHLORIDE
sodium chloride injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0338-0049 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) | SODIUM CHLORIDE | 9 g in 1000 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA016677 | 12/09/1970 | |
|
Part 2 of 27 |
SODIUM CHLORIDE
sodium chloride injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0264-7800 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698, SODIUM CATION - UNII:LYR4M0NH37) | SODIUM CHLORIDE | 0.9 g in 100 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA019635 | 03/09/1988 | |
|
Part 3 of 27 |
ATROPINE SULFATE
atropine sulfate injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0409-4910 |
Route of Administration | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, ENDOTRACHEAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ATROPINE SULFATE (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) | ATROPINE SULFATE | 0.1 mg in 1 mL |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA021146 | 01/19/2006 | |
|
Part 4 of 27 |
ATROPINE SULFATE
atropine sulfate injection |
|
Product Information |
Item Code (Source) | NDC: 76329-3339 |
Route of Administration | PARENTERAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
Atropine Sulfate (UNII: 03J5ZE7KA5) (ATROPINE - UNII:7C0697DR9I) | Atropine Sulfate | 0.1 mg in 1 mL |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 06/01/2000 | |
|
Part 5 of 27 |
EPINEPHRINE
epinephrine injection |
|
Product Information |
Item Code (Source) | NDC: 76329-3316 |
Route of Administration | INTRAVENOUS, INTRACARDIAC |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
Epinephrine (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) | Epinephrine | 0.1 mg in 1 mL |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 12/01/1976 | |
|
Part 6 of 27 |
EPINEPHRINE
epinephrine injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0409-4933 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
Epinephrine (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) | Epinephrine | 0.1 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
Sodium Chloride (UNII: 451W47IQ8X) | |
SODIUM METABISULFITE (UNII: 4VON5FNS3C) | |
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) | |
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA209359 | 03/10/2021 | |
|
Part 7 of 27 |
EPINEPHRINE
epinephrine injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0409-4921 |
Route of Administration | INTRAVENOUS, INTRACARDIAC, ENDOTRACHEAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
EPINEPHRINE (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) | EPINEPHRINE | 0.1 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
SODIUM CHLORIDE (UNII: 451W47IQ8X) | |
SODIUM METABISULFITE (UNII: 4VON5FNS3C) | |
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) | |
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 09/14/2005 | 01/01/2017 |
|
Part 8 of 27 |
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0409-1323 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 20 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
SODIUM HYDROXIDE (UNII: 55X04QC32I) | |
HYDROCHLORIC ACID (UNII: QTT17582CB) | |
SODIUM CHLORIDE (UNII: 451W47IQ8X) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA040302 | 12/09/2005 | |
|
Part 9 of 27 |
LIDOCAINE
lidocaine hydrochloride injection, solution |
|
Product Information |
Item Code (Source) | NDC: 63323-208 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 20 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
SODIUM CHLORIDE (UNII: 451W47IQ8X) | |
HYDROCHLORIC ACID (UNII: QTT17582CB) | |
SODIUM HYDROXIDE (UNII: 55X04QC32I) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA017584 | 09/05/2000 | |
|
Part 10 of 27 |
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride injection |
|
Product Information |
Item Code (Source) | NDC: 76329-3390 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) | LIDOCAINE HYDROCHLORIDE ANHYDROUS | 20 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
HYDROCHLORIC ACID (UNII: QTT17582CB) | |
SODIUM HYDROXIDE (UNII: 55X04QC32I) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA083173 | 06/01/2001 | |
|
Part 11 of 27 |
DEXTROSE MONOHYDRATE
dextrose monohydrate injection |
|
Product Information |
Item Code (Source) | NDC: 76329-3301 |
Route of Administration | PARENTERAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) | DEXTROSE MONOHYDRATE | 500 mg in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
Water (UNII: 059QF0KO0R) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | | 06/01/2000 | |
|
Part 12 of 27 |
DEXTROSE
dextrose monohydrate injection, solution |
|
Product Information |
Item Code (Source) | NDC: 0409-6648 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) | DEXTROSE MONOHYDRATE | 25 g in 50 mL |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA019445 | 12/02/2005 | |
|
Part 13 of 27 |
NITROGLYCERIN
nitroglycerin tablet |
|
Product Information |
Item Code (Source) | NDC: 68462-639 |
Route of Administration | SUBLINGUAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
NITROGLYCERIN (UNII: G59M7S0WS3) (NITROGLYCERIN - UNII:G59M7S0WS3) | NITROGLYCERIN | 0.4 mg |
|
Inactive Ingredients |
Ingredient Name | Strength |
CALCIUM STEARATE (UNII: 776XM7047L) | |
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) | |
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) | |
SILICA DIMETHYL SILYLATE (UNII: EU2PSP0G0W) | |
|
Product Characteristics |
Color | white (white to off white) | Score | no score |
Shape | ROUND (Flat faced) | Size | 4mm |
Flavor | | Imprint Code |
2;C
|
Contains | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA206391 | 08/19/2017 | |
|
Part 14 of 27 |
DIPHENHYDRAMINE HYDROCHLORIDE
diphenhydramine hydrochloride injection |
|
Product Information |
Item Code (Source) | NDC: 0641-0376 |
Route of Administration | INTRAMUSCULAR, INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) | DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg in 1 mL |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA080817 | 11/27/1972 | |
|
Part 15 of 27 |
EPINEPHRINE
epinephrine injection, solution, concentrate |
|
Product Information |
Item Code (Source) | NDC: 54288-103 |
Route of Administration | INTRAVENOUS |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
Epinephrine (UNII: YKH834O4BH) (EPINEPHRINE - UNII:YKH834O4BH) | Epinephrine | 1 mg in 1 mL |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA205029 | 08/08/2014 | |
|
Part 16 of 27 |
EASY CARE FIRST AID DIPHENHYDRAMINE
diphenhydramine hydrochloride tablet, film coated |
|
Product Information |
Item Code (Source) | NDC: 4422-0017 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M) | DIPHENHYDRAMINE HYDROCHLORIDE | 25 mg |
|
|
Product Characteristics |
Color | pink (pink) | Score | no score |
Shape | OVAL (OVAL) | Size | 11mm |
Flavor | | Imprint Code |
048;D
|
Contains | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 01/01/2012 | |
|
Part 17 of 27 |
ALCOHOL PREP
isopropyl alcohol swab |
|
Product Information |
Item Code (Source) | NDC: 67777-121 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ISOPROPYL ALCOHOL (UNII: ND2M416302) (ISOPROPYL ALCOHOL - UNII:ND2M416302) | ISOPROPYL ALCOHOL | 0.7 mL in 1 mL |
|
Inactive Ingredients |
Ingredient Name | Strength |
WATER (UNII: 059QF0KO0R) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part333A | 07/01/2010 | |
|
Part 18 of 27 |
MOORE MEDICAL NON ASPIRIN
acetaminophen tablet, film coated |
|
Product Information |
Item Code (Source) | NDC: 55670-467 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) | ACETAMINOPHEN | 325 mg |
|
|
Product Characteristics |
Color | white (white) | Score | no score |
Shape | ROUND (ROUND) | Size | 10mm |
Flavor | | Imprint Code |
AZ;234
|
Contains | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part343 | 12/30/2008 | |
|
Part 19 of 27 |
ASPIRIN
aspirin tablet, film coated |
|
Product Information |
Item Code (Source) | NDC: 55670-131 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) | ASPIRIN | 325 mg |
|
|
Product Characteristics |
Color | white (white) | Score | no score |
Shape | ROUND (ROUND) | Size | 10mm |
Flavor | | Imprint Code |
TCL;011
|
Contains | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part343 | 12/30/2008 | 08/31/2022 |
|
Part 20 of 27 |
MOOREBRAND ASPIRIN
aspirin tablet, film coated |
|
Product Information |
Item Code (Source) | NDC: 55670-616(NDC:50844-957) |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) | ASPIRIN | 325 mg |
|
Inactive Ingredients |
Ingredient Name | Strength |
STARCH, CORN (UNII: O8232NY3SJ) | |
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A) | |
PROPYLENE GLYCOL (UNII: 6DC9Q167V3) | |
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) | |
|
Product Characteristics |
Color | white | Score | no score |
Shape | ROUND | Size | 10mm |
Flavor | | Imprint Code |
Aspirin;44;157
|
Contains | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part343 | 10/05/2020 | |
|
Part 21 of 27 |
VENTOLIN
HFA
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 0173-0682 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
Inactive Ingredients |
Ingredient Name | Strength |
NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA020983 | 06/09/2006 | |
|
Part 22 of 27 |
ALBUTEROL SULFATE
HFA
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 66993-019 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
Inactive Ingredients |
Ingredient Name | Strength |
NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA authorized generic | NDA020983 | 01/15/2019 | |
|
Part 23 of 27 |
ALBUTEROL SULFATE
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 45802-088 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
Inactive Ingredients |
Ingredient Name | Strength |
ALCOHOL (UNII: 3K9958V90M) | |
NORFLURANE (UNII: DH9E53K1Y8) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA203760 | 02/26/2020 | |
|
Part 24 of 27 |
ALBUTEROL SULFATE
HFA
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 0093-3174 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
Inactive Ingredients |
Ingredient Name | Strength |
NORFLURANE (UNII: DH9E53K1Y8) | |
ALCOHOL (UNII: 3K9958V90M) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA021457 | 01/16/2019 | |
|
Part 25 of 27 |
ALBUTEROL SULFATE
albuterol sulfate inhalant |
|
Product Information |
Item Code (Source) | NDC: 69097-142 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 108 ug |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA209959 | 04/08/2020 | |
|
Part 26 of 27 |
ALBUTEROL SULFATE
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 0254-1007 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 108 ug |
|
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA authorized generic | NDA020503 | 04/03/2019 | |
|
Part 27 of 27 |
PROAIR
HFA
albuterol sulfate aerosol, metered |
|
Product Information |
Item Code (Source) | NDC: 59310-579 |
Route of Administration | RESPIRATORY (INHALATION) |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
ALBUTEROL SULFATE (UNII: 021SEF3731) (ALBUTEROL - UNII:QF8SVZ843E) | ALBUTEROL | 90 ug |
|
Inactive Ingredients |
Ingredient Name | Strength |
NORFLURANE (UNII: DH9E53K1Y8) | |
ALCOHOL (UNII: 3K9958V90M) | |
|
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NDA | NDA021457 | 12/03/2012 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
exempt device | ABC | 01/01/2015 | |
|